Membership Update – December 2012/January 2013

BioNJ welcomes Marke Communications as a new Diamond Members for 2012/2013:

Marke Communications Marke Communications is a full-service integrated marketing communications agency that has been in business for over 30 years. Our success is grounded in sound strategy, engaging creative and in the alliance we build with our clients. We are flexible and innovative with deep experience in healthcare marketing that allows us to understand the critical issues and regulatory changes facing today’s pharmaceutical industry. Headquartered on Fifth Avenue in New York City, we are keenly aware of what it takes to develop and implement the right strategic marketing programs utilizing integrated tactics that deliver results. Our unique structure allows us to conform to our clients’ needs with a unique combination of strategic insight and creative firepower.

We invite you to visit our diverse portfolio at www.marke.com.

BioNJ welcomes Advanced Pharmaceuticals, FluidDA, Geistlich Pharma, and S1Biopharma as new Core Members for 2012/2013:

Advanced Pharmaceuticals, LLC Advanced Pharmaceuticals, LLC, located in Plainsboro is an innovative biotechnology company focused on the development of a drug for a rare neurological disease known as Krabbe disease. It has also been working on the development of a diagnostic biomarker for early detection of cancers, especially head and neck cancer and prostate cancer. Advanced Pharmaceuticals, LLC was founded in early 2010 by Dr. Hossen Mahmud who is the Owner and President of the company. His wife, Amina Mahmud, is a Co-owner and Managing Director of the company.

FluidDA, Inc. FluidDA develops Functional Respiratory Imaging (FRI) Applications based upon CT analysis and Computational Functional Dynamics – CFD – methodology to accelerate Clinical Research for major research institutions, medical device companies and pharmaceutical companies. FluidDA’s set of repeatable measurements of lung structure and function is a novel Functional Respiratory Imaging Biomarker for diagnosis, staging and treatment of major lung disease. FluidDA is an established leader in quantitative image analysis for COPD, emphysema and asthma. FluidDA’s mission is to establish lung quantitative CT/CFD methods in the Clinical Research domain.

More information on: www.FluidDA.com .

Geistlich Pharma North America, Inc. Geistlich Pharma is the global leader in regenerative medicine in dental and oral-maxillofacial surgery with biomaterials targeted for bone and soft tissue regeneration. The company's

1 expertise in collagens extends to matrices for bone and cartilage regeneration in orthopedics, trauma and sports medicine. Geistlich Pharma also has a portfolio of proprietary pharmaceuticals and OTC products. Based in Switzerland, the company has a 160 year history of science based, high quality innovation.

More information can be found at: www.geistlich-pharma.com

S1Biopharma S1 Biopharma is a clinical stage biopharmaceutical company specializing in the discovery, development, and commercialization of drug therapies for Hypoactive Sexual Desire Disorder (HSDD) and related Sexual Dysfunctions.

BioNJ welcomes Bench International, Biotrial, ECMB, MPI Research, The Tustin Group and Yankee Public Relations as new Associate Members for 2012/2013:

Bench International Bench International is a global Women’s Business Enterprise (WBENC)-certified retained executive recruiting and consulting firm serving the life sciences sector exclusively since 1974. We pride ourselves as being one of the top executive recruitment providers for the sector, with a team that is deeply experienced and accomplished and has the content knowledge and expertise to translate and meet our clients’ needs and expectations for executive talent. Our vision, simply put, is to make life-changing placements so our clients can change lives. Bench International is headquartered in Los Angeles, California, with hubs in New York, the United Kingdom, Switzerland and Australia.

Biotrial Founded in 1989, Biotrial is a leading CRO specializing in Early Development with a large range of services from Non-Clinical Pharmacology, Phase I studies, Phase II-IV Trial Management, Bioanalytical analysis, Oncology, Data Management, Biostatistics, ECG & Imaging Core Lab (QT/QTc Trials, Psychometric Testing, Imaging, EEG/PSG Assessment), Regulatory Affairs to Medical Writing.

Based in France, Belgium, the United Kingdom, Canada and the United States, Biotrial performs hundreds of studies a year and offers tailor-made solutions to Biotech and Pharmaceutical companies. In the past year Biotrial has expanded its French Phase I Units in Paris and Rennes, has extended its state-of-the-art Non-Clinical facilities in Rennes, and has announced the location of the new 100-bed Phase I Clinic in Newark, NJ. Biotrial has recently reinforced its expertise in neurocognitive assessments and sleep quality evaluation through the acquisition of Forenap’s Medical & Scientific expertise and PD systems. At the end of 2012, Biotrial extended its service line to include Bioanalytical analysis with the acquisition of a Bioanalytical laboratory in Laval, Quebec, Canada.

For more information visit us at www.biotrial.com

ECBM ECBM is an Insurance Brokerage and Consulting firm providing strong employee benefit and risk management through strategic consulting since 1970. A privately held firm, we have grown significantly with our long-term focus, providing innovative solutions to our clients. ECBM understands our client’s business and effectively navigates their ever-changing environment.

2

No matter the size of the group, we offer a cost‐reduction process which will improve your programs. We have set standards that ensure professional delivery of the services allowing us to consistently exceed client expectations. Our preferred remuneration is directly negotiated fees. We welcome the opportunity to assist members. ECBM - Effective Cost Based Management.

MPI Research Our mission is to partner with biopharmaceutical and medical device companies globally to provide best-in-class, early-stage drug development services which ultimately results in safer, more efficacious products for the world. Our vision is to be recognized as the leading provider of early-stage drug development services through integrity, dedication, innovation, and focus with and among our Employees and our Sponsors.

The Tustin Group NJ The Tustin Group has been providing advanced HVACR mechanical system solutions for commercial, institutional and industrial customers in the Delaware Valley, Lehigh Valley and Southern New Jersey for over 20 years. Whether it is to maintain, upgrade or re-design your HVACR mechanical, building automation or water management system, you can depend on the Tustin Group’s expertise for accurate diagnostics, cost-effective solutions, and expertly trained sales and service professionals.

Yankee Public Relations Yankee Public Relations has over 25 years of experience leading proactive public relations and marketing communications initiatives for companies and organizations in the biopharmaceutical, healthcare and finance industries. We enable brand conscious clients of all sizes to achieve their business objectives through creative, multi-tiered communications initiatives. Yankee PR is a boutique communications firm that provides personalized service to clients and we take great pride in quickly responding to client needs. Yankee PR provides value-added communications services without the bureaucracy of larger firms. Public relations is a 24-hour, seven day week business and our commitment to clients illustrates this philosophy.

BioNJ thanks Buchanan Ingersoll & Rooney PC and Pfizer, Inc. renewing as Platinum Members for 2013:

Buchanan Ingersoll & Rooney PC Buchanan Ingersoll & Rooney PC has more than 450 attorneys and government relations professionals. The firm's bicoastal reach provides clients with nationwide access to all of our professional and their respective areas of experience.

Our attorneys have deep experience in the life sciences industries, in areas such as pharmaceuticals, biotechnology, medical devices, medical foods and dietary supplements. Other industries that we serve include financial services, energy, entertainment and media, real estate, national security, natural resources and technology. With regard to the biotechnology industry, our lawyers and professionals are particularly focused on helping clients with U.S. Food and Drug Administration (FDA) and regulatory strategy; Research and Development, lawful marketing and sale of FDA-regulated products, capital formation and corporate finance, intellectual property and patent prosecution; licensing, collaboration and strategic alliances; government relations; and medical coverage and reimbursement.

3

We are dedicated to building a deep understanding of our clients, their businesses and their industries. The proof of our commitment to client service is in what is said about us. Buchanan was recently named on the "Client Service A-Team" for the eighth year in a row in an independent survey conducted by national market research and management consulting firm BTI. The survey consisted of corporate counsel at large and Fortune 1,000 companies.

Pfizer Inc Pfizer Inc: Working together for a healthier world™ At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world’s leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more about our commitments, please visit us at www.pfizer.com.

BioNJ thanks Agile Therapeutics, Amgen, Inc. Bezwada BioMedical, Drais Pharmaceuticals, Elusys Therapeutics, HDL Apomics, Helsinn Therapeutics, HSP-USA, Immunomedics, Ipsen Biopharmaceuticals, Karykion, Mannkind Corporation, NPS Pharmaceuticals, Palatin Technologies, PanOpteca, Prolong Phrmaceuticals, Soligenix, Tactical Therapeutics and ThromboGenics for renewing as Core Members for 2013.

Agile Therapeutics, Inc. Agile Therapeutics is a specialty pharmaceutical company focused on developing and commercializing innovative women’s healthcare products that address unmet needs. Agile was founded in 1997 and is headquartered in Princeton.

Amgen, Inc. Amgen is a leading human therapeutics company in the biotechnology industry. For more than 25 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine. Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines.

Bezwada Biomedical LLC Bezwada Biomedical LLJ is an innovation-driven startup company catering to the unmet needs of the biomaterial community and medical device industry. With our state of the art research and development facilities in the U.S. and India, combined with our platform technologies derived from a family of novel and proprietary biodegradable polymeric biomaterials, we work with and for our customers to translate their demands into high quality products for a wide range of medical device and therapeutic applications in a cost effective manner. Our expertise lies in the area of absorbable polyurethane, absorbable polymers derived from functionalized natural products, drug molecules and amino acids, adhesion prevention barriers, absorbable drug eluting stent coatings, tissue adhesive and sealant, medical device coatings, drug delivery, drug device combination, absorbable implantable devices and tissue engineering.

4

Drais Pharmaceuticals, Inc. Drais Pharmaceuticals, Inc. is an ethical pharmaceutical company dedicated to the development of novel therapeutic treatments that address unmet medical needs and provide significant benefits over currently available therapies. The company consists of highly experienced, seasoned individuals with sustained, successful track records in the pharmaceutical industry.

Elusys Therapeutics, Inc. Elusys Therapeutics is a privately-held biopharmaceutical company focused on the development of antibody-based therapies for the treatment of infectious disease. The Company has pioneered the development of a rapid injection, therapeutic antibody, Anthim™, for the treatment of following a biowarfare attack.

HDL Apomics HDL Apomics is taking a high-density lipoprotein (HDL) – centric view as the basis for progressing our understanding of cardiovascular disease and its associated complications through risk profiling based on measuring the dynamic status of an individual’s HDL particle population. Currently in development, our multiplex antibody array will generate a high- definition “HDL fingerprint” directly from plasma. Fingerprint matching against our genetic and disease-state sample library enables assessment of cardiovascular disease and through proprietary analytics will develop validated biomarkers for diagnosis, risk assessment, and response to therapy. HDL Apomics will offer diagnostic services to the biotechnology and pharmaceutical industries to markedly improve success rates in clinical trials and reduce time to market, ultimately affording improved quality of patient care.

Helsinn Therapeutics, USA Helsinn Therapeutics USA is a privately held biopharmaceutical development company whose management has leadership experience with major pharmaceutical companies such as Roche, Merck, Aventis and Novartis. The team’s experience ranges through all aspects of drug development -- from research, safety assessment and manufacturing through regulatory affairs and commercialization. Our pipeline consists of first-in-class, composition-of-matter protected compounds acting within the ghrelin pathway.

HSP-USA, LLC HSP USA (www.hsp-usa.com) is a privately held biotechnology company that provides innovative clean technology for disinfection, water treatment and purification, environmental control and cleansing for industrial, commercial and healthcare applications. Our main products are SteriMixer machines and Hsp2O hospital grade disinfectant.

Immunomedics, Inc. Immunomedics is committed to being a leading, innovative biopharmaceutical company, dedicated to improving health and quality of life with novel immunotherapeutics for the treatment of cancer, autoimmune and other serious diseases. The company’s work is driven by scientific excellence and the highest standards, in a culture of integrity, pride and dedication.

Ipsen Biopharmaceuticals Ipsen is a global biopharmaceutical group. The Group’s specialty care franchise represents more than 60 percent of sales. Ipsen’s development is based on an original model geared towards innovation: commitment to a dynamic investment policy in Research and Development, with a focus on biotechnology (peptides, proteins, steroids and sustained-release formulations); specialization in four disease areas with high added value (oncology, endocrinology, neurology, hematology) and an historic presence in primary care; an active partnership policy with 5 outstanding research centers and international pharmaceutical companies. Through its long- term development plans, the Group aims to transform its knowledge of life sciences into innovative medicines for both physicians and patients.

Karykion, Inc. Karykion, Inc. has specialties in three therapeutic areas of pharmaceutical research. The first concerns the development of anti-fungal, for the treatment of enveloped virus related disease. The second area of research deals with the identification and treatment of cholesterol related disease. The research includes studies with cholesterol absorption inhibiting compounds and examining the impact of these products on benign tumor activity. The third area of experimentation has involved the development of products to facilitate the removal of arthropods from living epidermal tissue. The primary species the company has been addressing are ticks.

MannKind Corporation Mankind Corporation is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. The Company’s lead investigational product candidate, AFRESA®, is an ultra rapid- acting insulin drug.

NPS Pharmaceuticals, Inc. NPS Pharmaceuticals develops specialty therapeutics for gastrointestinal and endocrine disorders, such as its two late-stage registration studies for intestinal failure associated with short bowel syndrome and hormone replacement therapy for hypoparathyroidism.

Palatin Technologies, Inc. Palatin Technologies is a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics. The Company’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.

PanOptica,Inc. PanOptica, Inc. is a private biopharmaceutical company focused on licensing and developing innovative ophthalmology therapies. The Company was founded in March 2009 by co-founders Paul Chaney, past president of OSI Eyetech and Martin Wax MD, who formerly headed Pharmaceutical R&D at Alcon.

In December 2010, PanOptica, Inc. raised $30 million in a Series A financing led by SV Life Sciences and Third Rock Ventures. The completion of this financing coincides with the company’s successful licensing of exclusive worldwide ophthalmic rights to PAN-90806 from OSI Pharmaceuticals, Inc., a wholly-owned subsidiary of Astellas US Holding, Inc. for the treatment for neovascular age-related macular degeneration, also known as wet AMD.

Prolong Pharmaceuticals LLC Prolong Pharmaceuticals, based in South Plainfield, NJ, (www.prolongpharmaceuticals.com) is developing products targeting anemia resulting from oxygen deficiency. The company's clinical development efforts are focused on sickle cell anemia, diabetic ischemia, and several trauma indications. Prolong is also advancing a long-acting 3rd generation biologic for treating anemia due to chronic kidney disease and cancer treatment. The company is privately owned and is managed by an experienced team of biopharmaceutical executives, including BIONJ’s original founder Dr. Abraham Abuchowski.

6

Prostrakan USA An international pharmaceutical company based in Galashiels, Scotland whose focus is developing prescription medicines for the treatment of unmet medical needs. In the United States, the Company’s primary focus is the product areas of chemotherapy-induced nausea and vomiting, men’s health and pain relief.

Sentinella Pharmaceuticals, Inc. Sentinella was formed to acquire and develop NAI-107, an experimental with a novel mechanism of action for the treatment of serious nosocomial caused by gram-positive bacteria. The Company acquired the compound, together with a basket of promising related assets, from Naicons, an Italian research institution with a remarkable pedigree in the antibacterial field, in September 2009.

NAI-107 is the most advanced member of a novel class of antibacterials known as lantibiotics, naturally-occurring compounds produced by fermentation. In vitro and in animal models of systemic bacterial infection, NAI-107 has shown best-in-class potency and spectrum of activity against difficult to treat bacterial strains, including resistant bacteria species such as Methicillin- Resistant S.Aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE) that are becoming a growing public health threat. Other attractive features of this compound include its rapid bactericidal activity, a low propensity for development of resistance and a promising pharmacokinetic profile. Because NAI-107 is one of very few truly novel antibacterial compounds in active development, the drug could play a very prominent role in the continuing fight against resistant pathogens.

Soligenix, Inc. Soligenix, Inc., formerly known as DOR BioPharma, Inc., is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain agents. Soligenix’s lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of GI GVHD.

Tactical Therapeutics, Inc. Tactical Therapeutics, Inc. (“Tactical”) is a virtual biopharma company located in New York City. Tactical’s platform technology development of safer and deliverable small molecules by chemical restructuring of drugs. Currently Tactical is testing its lead multi-targeted drug, CTO in Phase I and IIA exploratory trials in glioblastoma multiforme. The strategy of using a combination of CTO (P13K/MAPK/VEGF/Ca signal inhibitor) and approved cytotoxic agents has more than additive effects in preclinical models on efficacy and overall survival. Tactical intends to develop this strategy for more solid tumors (melanoma, thyroid, pediatric, GBM, etc.) based on a personalized and translational medical approach.

ThromboGenics Inc. ThromboGenics (Euronext Brussels: THR) is a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of eye disease, vascular disease, and cancer. Our lead product, ocriplasmin, has completed two successful phase III clinical trials for the pharmacological treatment of symptomatic vitreomacular adhesions, including macular holes, a common source of vision loss in the elderly, and will be submitted to the FDA during 4Q 2011. ThromboGenics will commercialize this product via its own dedicated organization based in Iselin.

7

BioNJ thanks INSMED and Lexicon Pharmaceuticals for renewing as core members for 2012.

INSMED INSMED, Inc. is a biopharmaceutical company focused on developing innovative, inhaled pharmaceuticals for the site-specific treatment of serious lung diseases, such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. The Company is committed to significantly improving the quality of life and healthcare of patients suffering from these life- threatening diseases.

Lexicon Pharmaceuticals, Inc, Lexicon Pharmaceuticals is a biopharmaceutical company that uses its proprietary “gene knockout technology” to find physiological and behavioral functions of thousands of genes. The Company is working to translate their discoveries into medicines that will fight human diseases with a primary focus in the fields of cardiology, gastroenterology, immunology, metabolism and ophthalmology.

BioNJ thanks JFK Communications and Korn/Ferry International for renewing as Associate Members for 2012.

JFK Communications Inc. JFK Communications is a healthcare public relations firm that partners with specialty pharmaceutical, biotechnology and medical technology companies. If you need a strategic communications firm whose knowledge is exceeded only by its passion, we’re ready to help.

Korn/Ferry International Korn/Ferry International, with a presence throughout the Americas, Asia Pacific, Europe, the Middle East and Africa, is a premier global provider of talent management solutions celebrating 40 years in business. Based in Los Angeles, the firm delivers an array of solutions that help clients to attract, develop, retain and sustain their talent. Korn/Ferry’s Global Life Sciences and Healthcare Services practice leads the marketplace in number of engagements within the industry, having conducted more than 4,000 searches worldwide in the last four years. Visit www.kornferry.com for more information on the Korn/Ferry International family of companies, andwww.kornferryinstitute.com for thought leadership, intellectual property and research.

BioNJ thanks 6 Degrees Communication, Ashton Tweed, Auld Consultation, Berkley Life Sciences, BioPharm Associates, BioScience Expansion, Chemical and Pharmaceutical Solutions, Domain Associates, Edwards Wildman, Epsen Fuller/IMD, Greenberg Traurig, Mancino, Barfield Edgerton, PharmaApprove, Scientific Search, Silicon Valley Bank, Sorin Rand, The Charles Group, William H. Connolly & Co., YourEncore for renewing as tAssociate Members for 2013:

6 Degrees Communications 6 Degrees Communications has that unique combination, as a results-oriented, full-service public relations firm that serves clients across the health-care spectrum. We deliver experiences that are meaningful, tangible, quotable, distinguishable and indelible, setting our work apart from our competition. Our offering is unique in three ways. First, our plans focus on your business objectives. A signature media placement is of little use if it doesn’t move an

8 organization closer to its goals. Second, we are defined by our relationships. No other health care firm is more skilled at forging relationships. Finally, we execute. Plans are only as good as the people implementing them, and our nimble, senior-based model means we deliver business- changing results.

At 6 Degrees, we are uniquely positioned to help transmit messages through that web by leveraging our unparalleled experiences gained and relationships earned inside the world’s most powerful media institutions, regulatory bodies and corporations. Our team brings distinctive perspectives, specifically that of public relations professionals, corporate communicators, federal regulators, policy and news media. We move seamlessly between services including FDA panel preparation, issues management, media platform creation and execution, executive positioning, thought-leadership and communications. It is this insider’s knowledge of how different systems work that distinguishes our approach.

Ashton Tweed, LTD Ashton Tweed is a robust professional force of highly experienced Life Sciences Industry experts who are deployed throughout the Company’s diverse range of service offerings to solve clients’ human capital and commercialization management needs. The Company excels in finding the right candidates for clients’ workforces at all points of growth and across all specialized staffing needs.

Auld Consulting LLC “Finding someone who understands the Human Resources issues specific to the biotech and pharmaceutical industry can be difficult, especially for small and start-up companies with tight budgets. Auld Consulting LLC is their HR department or assists existing staff as needed. With Auld Consulting companies have access to an expert without the expense of a staff member.”

Berkley Life Sciences Berkley Life Sciences is a wholly owned subsidiary of W. R. Berkley Corporation. We offer an array of property and casualty insurance products designed for the Life Sciences industry. We are the only insurance company focusing solely on insuring those in the Life Sciences field. Berkley Life Sciences offers its products and services through select retail and wholesale distribution channels. W. R. Berkley Corporation is one of the nation’s premier commercial lines property casualty insurance providers.

BioPharm Associates, LLC BioPharm Associates is a project management company whose focus is on improving business results and value for corporations. The Company develops the skills and managerial attention needed to create business success for biopharmaceutical corporations across the globe.

BioSciences Expansion BioSciences Expansion specializes in helping French and European companies introduce and develop their businesses in the U.S. Focusing on small to midsized companies in the Life Sciences industry, BioSciences Expansion designs customized programs and manages their successful implementation so that European companies can optimally establish and grow their businesses. The company provides comprehensive services and solutions from strategic planning to operational development and execution. Taking full advantage of our transatlantic expertise, companies achieve their goals in shorter timeframes while avoiding costly delays and mistakes. With its network and partners, BioSciences Expansion provides a unique combination of scientific and business expertise.

9

Chemical and Pharmaceutical Solutions Chemical and Pharmaceutical Solutions was founded in 2002. Our primary focus is servicing the emerging pharmaceutical market and to assist those companies in developing and commercializing their API’s. We look at both the technical and regulatory aspects of taking a product from early development through commercial launch. Working with outside partners, we look at economic drivers of your process and the technical challenges around scale-up including improved purification methods as well as continuous flow chemistry. We also work closely with the venture capital firms to evaluate the technical and regulatory aspects of potential licensed products.

Domain Associates, LLC Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on life sciences. With $2.5 billion of capital under management, Domain has offices in Princeton and San Diego, CA. Domain's three major investment segments are pharmaceuticals, specialty pharmaceuticals, and medical devices, while additional areas of interest include biomaterials, bioinstrumentation, and diagnostics. The Partners of Domain have a total of close to 200 person-years of experience among them in the healthcare/venture capital industries and have been involved in the formation and growth of more than 210 life-sciences companies. For further information, visit www.domainvc.com.

Edwards Wildman LLP Edwards Wildman has been at the forefront of life sciences for 30 years. We have grown with the industry and have more than 70 lawyers supporting life sciences companies, investors, universities, medical centers, and research foundations in their efforts to bring life-saving discoveries to market. Forty of our team members have life sciences degrees, 16 of those are Ph.D.s We work with over 200 clients in biotechnology, pharmaceuticals, medical devices and healthcare technologies. Some clients are early stage, researching new therapies for cancer and others distribute branded drugs to the world’s markets. Whatever the legal issue, Edwards Wildman can provide the guidance, depth and experience to help achieve your commercialization goals. Edwards Wildman is an international law firm with 15 offices in the US, UK and Asia, including Madison, New Jersey.

Epsen Fuller/IMD New Jersey based Epsen Fuller/IMD International Search Group, www.epsenfuller.com, is among the world’s Top-20 retained executive search and consulting firms with over 150 consultants and offices in all the major markets around the globe. With global reach, Epsen Fuller/IMD conducts assignments for senior level and mid- management talent throughout the life sciences to include biotechnology, medical devices & pharmaceuticals. The firm’s Performance Based AssessmentSM approach ensures superior talent acquisition enabling clients to build a sustainable talent advantage.

Greenberg Traurig Greenberg Traurig is an international law firm with more than 1,800 attorneys and governmental affairs professionals in 32 commercial and government centers across the US and in Europe and Asia. The firm was selected as the 2007 USSA Law Firm of the Year by Chambers and Partners. GT provides integrated, business-focused legal services for clients ranging from innovative start-ups to Fortune 500 corporations. Our multidisciplinary team includes senior lawyers who have been the chief legal officers at major multinational companies and have spent years solving real-world problems in the business, political and legal arenas.

10

Mancino Burfield Edgerton Mancino Burfield Edgerton has over 25 years of experience successfully conducting retained searches. We are results oriented and have a track record of providing quality and timely professional recruitment and business advisory services to our life science client. We are engaged routinely by Fortune 500 companies, midsize as well as emerging, venture-backed start ups.

PharmApprove PharmApprove is a strategic scientific communications firm that partners with pharmaceutical development teams to assist in the preparation and delivery of their products’ key messages at critical, high-profile regulatory events in both the United States and Europe. By working intensively with team members as well as with the material they present, PharmApprove helps sharpen the product message and enhance each team member’s ability to speak clearly, argue persuasively, and answer questions decisively in virtually any regulatory setting.

The firm offers a comprehensive range of services covering every aspect of hearing preparation. Those services include strategy and message development; briefing package and presentation development; slide composition and organization; Q&A development and management; speaker, bullpen and media training; project management; mock panel production; and onsite services.

PharmApprove was established in 1999 as a division of Taft and Partners, an integrated communications agency based in Princeton, New Jersey which specializes in high-profile presentations and communications in other industries. In addition to its core service of hearing preparation, PharmApprove conducts half-day and daylong workshops on a variety of topics, facilitates “lessons learned” retreats and global meetings, produces instructional videos on the FDA and Advisory Committees, and trains pharmaceutical executives in one-on-one presentation and Q&A skills sessions. Other services include support of all major milestone drug development events including business development meetings, Advisory Board meetings, investor presentations, and preparation for reimbursement agencies.

Scientific Search Scientific Search has been placing M.D.s, Ph.D.s, Regulatory Affairs, Quality Assurance, Pre- Clinical and Clinical Development and Management, Pharmacovigilance, Toxicology, Engineering, Market Research, R&D, Information Technology, and related professionals at the technical, management and executive levels since 1983. This includes significant work throughout the Mid-Atlantic region and the US. Our firm has very extensive resources in terms of recruiters and most importantly biotechnology industry contacts which enable us to find the right people quickly. We fill full time direct, as well as temporary, and temp to direct positions. Additional information is available at www.scientificsearch.com.

Silicon Valley Bank For 25 years, Silicon Valley Bank has been dedicated to providing global financial services to some of the most innovative and entrepreneurial companies in the technology, life science, private equity and premium wine industries. Our experience with these industries affords us a deep understanding of our clients' business models and a high level of comfort with the business cycles inherent to these dynamic markets.

SorinRand LLP Twenty-first Century business realities, driven by enhanced productivity tools, increased competition, a volatile, rapidly changing economy, and the unique needs of and challenges 11 confronted by clients, are creating paradigm shifts in the delivery of legal services. We created SORINRAND to reinvent law firm practice to address these issues, especially for clients in the emerging growth and middle market sectors, including technology, communications, internet, alternative energy, nanotechnology, and life sciences. We provide creative and sophisticated solutions characterized by the highest-quality lawyering and responsive service. Our counsel is imbued with a businessperson’s sensibility and offered at a common sense fee structure. As a result, we provide a compelling value proposition. SORINRAND is comprised of lawyers long recognized as practice and thought leaders in the service of emerging growth and middle market sector companies, and the investors, directors, and officers who serve them. We join our expertise, deep and broad experience, strict adherence to core values and principles, and results-oriented approach with a commitment to a low-cost infrastructure. By focusing on cost containment and employing a lower leverage model, we offer fees that are up to 50 percent less than those of our primary competitors. At the same time, we are deeply committed to employing the highest quality lawyers and offer compensation packages designed to attract the very best. Our rapidly growing roster of clients continues to demonstrate how well our alternative solution resonates with the business and investment communities.

The Charles Group, Inc The Charles Group, Inc. is a full-service domestic and international meeting planning and consulting firm. We offer clients a comprehensive range of services spanning a wide spectrum – from retreats for small groups of executives…educational conferences and advisory board client entertainment events with thousands in attendance and everything in between. We welcome working either in place of your internal staff or as an extension of their capabilities. Regardless of the scope of the assignment, we are committed to providing our clients with the highest quality service.

Unforgettable meetings and special events…anywhere in the world.

William H. Connolly & Co., LLC William H. Connolly & Co., LLC serves the insurance and risk management needs of a large and diverse group of businesses: biotechnology, healthcare, pharmaceutical, social service organizations, professional services and individuals. Our reputation for excellence and integrity and our ability to meet the evolving needs of our clients drives our success. Aggressive and innovative in our pursuit of solutions to insurance and risk management challenges, William H. Connolly & Co., LLC is widely recognized for our expertise.

YourEncore, Inc. YourEncore is a US-based innovation services company that taps into our country’s under- utilized asset: the growing number of veteran/retired scientists, engineers and life sciences professionals. We connect our Member Companies with experienced Experts from all aspects of scientific disciplines to leverage their expertise and accelerate innovation. YourEncore Experts specialize in the life sciences, consumer sciences, food sciences, as well as the aerospace and defense industries. These experts come from over 1,000 different companies and organizations.

CLICK HERE to return to main page.

12